Risk factors for peripheral neuropathy in patients on linezolid-containing regimens for drug-resistant TB

Int J Tuberc Lung Dis. 2023 Mar 1;27(3):232-234. doi: 10.5588/ijtld.22.0423.

Authors

Y S Kwon¹, J G Jang², J Lee³, K-J Choi⁴, J E Park³

Affiliations

¹ Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea.
² Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea.
³ Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
⁴ Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Republic of Korea.

PMID: 36855040
DOI: 10.5588/ijtld.22.0423

No abstract available

Publication types

Letter

MeSH terms

Humans
Linezolid / adverse effects
Peripheral Nervous System Diseases* / chemically induced
Risk Factors
Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

Linezolid